Medifest 2009 to be held in New Delhi

DELHI IS all set to host the fourth edition of one of the biggest medical and healthcare technology trade events in India– ‘Medifest 2009’ from December 11 to 13, 2009, at Pragati Maidan. It would be a grand show delivering diverse assemblages of elites playing a major role in creating awareness in the society and educating people about the latest advancements in the healthcare sector.

“The main objective behind Medifest, is to bring together all those related with the medical and healthcare sector under one roof and provide to the health, wellness and pharma sector, the opportunity to pick and choose from the best of the technology and products world over. The event will facilitate transaction of significant volume of exports and domestic orders and will take India to new heights in the field of medical world” said Roohit Madan, chief executive officer, Vantage Trade Fairs (P) Ltd, the organisers of Medifest, 2009. Further he adds an expansion drive worth Rs 6,000 crore in NCR area only has already been initiated by leading corporate hospitals and major player like Fortis Healthcare Ltd, Moolchand Medicity, Medicity Gurgaon etc.

Medifest 2009 would be visited by a gamut of members from the medical and paramedical fraternity including doctors, scientists, paramedics, hospitals, manufacturing and pharmaceutical houses, R&D organisations, government agencies, medical institutes, importers, distributors, retailers etc.

NuvaRing launched in India

With the introduction of a product that will augment the contraception options currently available to Indian women, NuvaRing, the first vaginal birth control ring was formally launched in India. NuvaRing is a once-monthly vaginal ring that offers the same benefits as ‘the Pill’ but with the added convenience of not having to be used daily.

NuvaRing is a flexible, transparent ring containing hormones that are dispersed throughout the ring’s core and absorbed through the vaginal lining directly into the bloodstream, when inserted. The exact positioning of the ring is not critical for it to work. Additionally, the ring works, like ‘the Pill’, by inhibiting ovulation. In order to prevent pregnancy for a full month, NuvaRing must be inserted and left in place for three consecutive weeks. After a one week ring-free interval, a new ring must then be inserted in order to have continued contraceptive effect.